Read news as it happens
Create a Rediffmail account
Subscribe via RSS
5 more manufacturers to produce black fungus drug: Govt
The Union health ministry on Friday said license has been given to five more manufacturers for production of Amphotericin-B, used in the treatment of black fungus, and they will start producing......
Cipla to price Remdesivir for Covid-19 under Rs 5,000
Hetero has priced the injectable drug at Rs 5,400 per 100 mg vial. With more drugmakers in line to launch the drug soon, the prices may see a further erosion. Sohini Das reports. IMAGE: An......
India's pharma cos hit by 'China-made disruptions'
Chinese suppliers typically raise prices of bulk drugs and other raw materials whenever they see an opportunity, and once the formulation makers turn to local suppliers in India, then suddenly......
'Why the fuss over hydroxychloroquine?'
'India is a pharma dada. We can manufacture enough for our people and for the world.' IMAGE: Doctors check patients at the Government Medical College hospital in Jammu. Photograph: PTI Photo......
Coronavirus crisis pushes India to work on drug security
The current crisis has forced the government to announce measures to ensure that India becomes self-sustaining for any kind of bulk drug.The government says India will not depend on any other......
Should pharma MNCs be peeved?
To conclude from the judgment that the country has scant respect for patents appears far-fetched, notes Bhupesh Bhandari.Multinational pharmaceutical companies complain that India has become a......
BDR wrestles Big Pharma in patents match
A month ago, Dharmesh Shah had enough time to spare for day-to-day activities of a lesser-known company -- BDR Pharma -- where he serves as chairman & managing director.However, in the last one......
Top Coverage News
US Presidential Elections 2016
Coming to India and making
Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
India, through the eye of a camera
Commonwealth Games - 2014
The defence coverage of Rediff.com
Office email App
© 2022 Rediff.com